Bausch Health Companies | VRX - Net Income


Bausch Health Companies reported $258M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Amgen USD 2.38B 556M Jun/2026
ANI Pharmaceuticals USD 29.49M 2.86M Mar/2026
Aurora Cannabis CAD -71.1M 72.92M Mar/2026
Bausch Health Companies USD 258M 1.68B Jun/2026
Biogen USD 97.5M 222M Jun/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Canopy Growth CAD -157.11M 94.49M Mar/2026
Corcept Therapeutics USD 42.14M 73.9M Jun/2026
Danaher USD 870M 159M Jun/2026
Drreddys Laboratories INR 2.21B 9.89B Mar/2026
Eli Lilly USD 7.1B 301M Jun/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
Nektar Therapeutics USD -44.9M 8.82M Mar/2026
Novo Nordisk DKK 20.99B 5.9B Jun/2026
Pacira USD 4.65M 1.74M Jun/2026
Perrigo USD 74.5M 473.1M Jun/2026
Phibro Animal Health USD 27.46M 932K Dec/2025
Prestige Brands USD 38.54M 15.39M Jun/2026
Supernus Pharmaceuticals USD -58.37M 56.08M Jun/2026
Vertex Pharmaceuticals USD 1.1B 68.4M Jun/2026
Zoetis USD 691M 90M Jun/2026